The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.
| Application Number | 5474002 |
| Trademark Status | Accepted & Advertised |
| Trademark Class | 99 |
| Application Date | 2022-06-03 |
| Proprietor Name | Replicate Bioscience, Inc. |
| Appropriate Office | DELHI |
| State | DELHI |
| Trademark Type | WORD |
| User Details | Proposed to be used |
| Agent Name | LALL & SETHI[23687] |
| Agent Address | D-17, South Extension Part II, New Delhi 110049, India |
| Goods And Services Details | [CLASS : 5] Pharmaceutical and biologic preparations; Biological components being a component in vaccines; Therapeutic agents and immunotherapies for the treatment of cancer, autoimmune diseases, inflammatory diseases, and infectious diseases; Biological compound for medical use, namely, self-replicating RNAs delivered into patient cells for creating therapeutic proteins; Therapeutic agents for generating or evading protective immune response[CLASS : 42] Research and development services in the fields of self-replicating RNAs, RNA therapeutics, pharmaceuticals, biologics, therapeutic proteins, cancer, autoimmune diseases, inflammatory diseases, and infectious diseases; Providing medical scientific information in the fields of self-replicating RNAs, RNA therapeutics, pharmaceuticals, biologics, therapeutic proteins, cancer, autoimmune diseases, inflammatory diseases, and infectious diseases |
Similar trademarks found for this brand
| Brand | Class | Status |
|---|---|---|
| REPLICATE | 99 | Accepted & Advertised |
Common questions about REPLICATE.